Evergreen Theragnostics
Latest round
- Series A
Last raised
- Apr 2020
Total raised
- $19M
Investors
- 1
About Evergreen Theragnostics
Founded in 2019 and based in New Jersey, US, Evergreen Theragnostics, Inc. operates as a platform for the pharmaceutical sector, providing antibodies and radiopharmaceutical procedures along with contract development and manufacturing. James Cook (CEO) and Serge Lyashchenko are the co-founders of the company. In April 2024, Evergreen Theragnostics, Inc. In January 2025, Lantheus Holdings, Inc. acquired Evergreen Theragnostics, Inc.5 million upon achieving milestones. The company provides services spanning from discovery to manufacturing, supporting the development and production of medical products. The firm’s key product is OCTEVY™, a kit designed for the preparation of Ga 68 DOTATOC injection. OCTEVY™ holds the advancement in radioactive diagnostic agents. This product develops solutions that enhance medical imaging and diagnostic capabilities and are specifically indicated for use with positron emission tomography (PET). Evergreen Theragnostics’ portfolio of services encompasses radiochemistry development, early-stage manufacturing, late-stage and commercial manufacturing, and an alpha therapy line.
Who invested in Evergreen Theragnostics
1 investor across 1 round
See all investors in Evergreen Theragnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 27, 2020
Amount
$19M
Investors
Questions about Evergreen Theragnostics
Who invested in Evergreen Theragnostics?
Evergreen Theragnostics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evergreen Theragnostics raised?
Evergreen Theragnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Evergreen Theragnostics last raise money?
Evergreen Theragnostics's most recent round on record is a Series A, in Apr 2020.
What does Evergreen Theragnostics do?
Founded in 2019 and based in New Jersey, US, Evergreen Theragnostics, Inc.
Where is Evergreen Theragnostics headquartered?
Evergreen Theragnostics is headquartered in Springfield, US.
Which VCs invest in companies like Evergreen Theragnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Evergreen Theragnostics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Evergreen Theragnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.